GlassScriptPhysician profile
David Hassan Rustom
NPI 1073877320
$6,404.43
in general payments reported to CMS, 2019-2025
15 companies · $967 in 2025
The $967 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.63 · 2020: $116 · 2021: $454 · 2022: $575 · 2023: $2,054 · 2024: $2,161 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,110 · Travel and Lodging: $672 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,110.13 |
| Travel and Lodging | $671.75 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $1,957.62 | 2022-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $1,307.87 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $528.23 | 2019-2024 | Senza |
| Abbott Laboratories | $479.76 | 2022-2025 | Proclaim |
| Spr Therapeutics, INC | $446.14 | 2020-2025 | Sprint Pns System |
| Vertos Medical, INC. | $434.77 | 2021-2024 | Mild Device Kit |
| Boston Scientific Corporation | $408.97 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $224.50 | 2025 | Senza |
| Abbvie INC. | $224.49 | 2023-2024 | Botox |
| Si-Bone, INC. | $183.23 | 2021-2025 | |
| Stryker Corporation | $123.84 | 2025 | Spinejack |
| Averitas Pharma INC. | $30.44 | 2023 | Qutenza |
| Allergan, INC. | $25.70 | 2019 | |
| Grt US Holding, INC. | $15.37 | 2022 | |
| Saluda Medical Americas, INC. | $13.50 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rustom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.